San Diego
20-24 May

APA’s Annual Meeting is the premier psychiatry event of the year. With over 450 educational sessions and courses, there is no better event to help you expand your knowledge, network, and meet certification and licensure requirements.

To arrange a meeting with the NeuroCog Trials team at the conference, please contact:

Jenna Piunti
+1 919 433-2429
jenna.piunti@neurocogtrials.com

Miami
29 May – 2 June 2017

The meeting will include representatives from academia, the National Institutes of Health (NIH), Food and Drug Administration (FDA), European regulatory agencies and industry that discussed key aspects of neuropsychiatric drug development, including the impact of diagnostic changes and personalized interventions based on biomarkers or genetic information.

To arrange a meeting with the NeuroCog Trials team at the conference, please contact:

Jenna Piunti
+1 919 433-2429
jenna.piunti@neurocogtrials.com

Düsseldorf
7-8 June 2017

The International MS Cognition Society (IMSCOGS), founded in 2011, aims at bringing together researchers and clinicians who are engaged in the care of MS patients and who have a special interest in cognition. With its Annual Meetings IMSCOGS offers an international platform for discussions on a highly relevant topic which is still underestimated and underrepresented at other conferences.

The target audience for the conference includes neurologists, neuropsychologists, clinical psychologists,  neuroradiologists, neuroscientists, nursing professionals, rehabilitation specialists, and other related healthcare professionals. The conference especially encourages young researchers and clinicians to attend and present current work related to the context of the session topics.

To arrange a meeting with the NeuroCog Trials team at the conference, please contact:

Jenna Piunti
+1 919 433-2429
jenna.piunti@neurocogtrials.com

Paris
31 August – 2 September 2017

The International Society for CNS Clinical Trials and Methodology (ISCTM) is a multi-disciplinary independent organization, devoted to promoting advances that address strategic clinical, regulatory, methodological and policy challenges that arise in the development and use of CNS therapeutic agents. This work is accomplished through partnership with persons in academia, industry, government, policy-making, and the public.

To arrange a meeting with the NeuroCog Trials team at the conference, please contact:

Jenna Piunti
+1 919 433-2429
jenna.piunti@neurocogtrials.com